[Congressional Record Volume 147, Number 90 (Tuesday, June 26, 2001)]
[House]
[Pages H3598-H3600]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]
PRESCRIPTION DRUG PRICES
The SPEAKER pro tempore (Mr. Kerns). Under the Speaker's announced
policy of January 3, 2001, the gentleman from Vermont (Mr. Sanders) is
recognized for 20 minutes as the designee of the minority leader.
Mr. SANDERS. Mr. Speaker, I want to thank the gentleman from New
Jersey (Mr. Pallone) for making some of his time available to me.
Mr. Speaker, I want to tell a story tonight about what happens when
an industry with unparalleled greed operates and spends huge sums of
money, with the result that they are destroying the health and well-
being of millions of Americans. And the industry that I am talking
about, sadly enough, is the pharmaceutical industry.
Mr. Speaker, I think, as my colleagues know, millions of Americans
today cannot afford the outrageously high cost of prescription drugs in
this country. Some of these people will die because they are unable to
purchase the prescription drugs that their physicians prescribe to
them. Many of them will just continue to suffer, not being able to get
the alleviation for their pain because they cannot afford those
prescription drugs. Others will buy the prescription drugs by taking
money out of their food budget or their heat budget and will do without
other basic necessities of life in order to purchase prescription
drugs.
Disgracefully, Mr. Speaker, tragically, the American people pay by
far the highest prices in the world for prescription drugs. It is not
even close. Several years ago, I took a number of Vermonters over the
Canadian border into Montreal because they could not afford the very,
very high prescription drug prices in our own country. And what we
found when we went over the border to Montreal is that the same exact
drugs, manufactured and sold in the United States, were sold for a
fraction of the cost an hour away from where my constituents were
living in northern Vermont.
Some of the women who went with me over the border were fighting for
their lives against breast cancer, an affliction that affects large
numbers of women in this country. And what they found when they went
across the border with me is that tamoxifen, a widely prescribed breast
cancer drug, was selling in Canada for one-tenth the price, 10 percent
of the price, that it is sold in the United States. Imagine that, women
who are struggling for their lives are forced to pay ten times more in
the United States than our neighbors are paying in Canada for the same
exact drug manufactured by the same exact company.
It is not just Canada and it is not just Mexico. In the southern part
of
[[Page H3599]]
our country, California, Texas, and Arizona, Americans are going across
our southern borders into Mexico for the same exact reason that
Americans in the northern part of this country are going into Canada.
But it is not just Mexico and Canada that have substantially lower
prices for prescription drugs. It is every other major country on
Earth.
Mr. Speaker, for every $1 spent in the United States for a
prescription drug, those same drugs are purchased in Switzerland for 65
cents, the United Kingdom for 64 cents, France for 51 cents, and Italy
for 49 cents. The same exact drugs. Meanwhile, while the pharmaceutical
industry rips off the American people, causes death, causes suffering,
that same industry year after year is at the top of the charts in terms
of profits.
Last year, for example, the top 10 pharmaceutical companies earned
$26 billion in profit. Twenty-six billion dollars. Why is it that
prescription drug prices are higher in the United States than in any
other industrialized country? Well, the answer is pretty obvious. The
pharmaceutical industry is perhaps the most powerful political force in
Washington and has spent over $200 million in the last 3 years on
campaign contributions, lobbying, and political advertising. Twenty
million dollars in the last 3 years in order to make sure that Congress
does not lower the outrageously high cost of prescription drugs and
affect their profits. Two hundred million dollars.
We see that money spent. We see it in the TV ads in our homes, on our
home television stations. We see it in the full page ads in the
Washington papers and in papers all over this country. Amazingly, not
only are they spending money on advertising, not only do they spend
money on campaign contributions, but the vast majority of Members of
Congress receive money from the pharmaceutical industry. The political
parties receive money from the pharmaceutical industry in soft money.
But even more amazing, the pharmaceutical industry has on their payroll
almost 300 paid lobbyists right here on Capitol Hill. Imagine that.
There are 535 Members of Congress, 100 in the Senate, 435 in the House,
and they have 300 paid lobbyists, including former Senators, former
Members of the House, knocking on our doors every day, saying, hey, do
not do anything to lower the cost of prescription drugs. Keep our
profits high, and we will make sure you get your campaign
contributions.
This is an absolute disgrace to democracy and it is an outrage being
perpetrated against millions of Americans who want nothing more than to
be able to purchase reasonably priced prescription drugs. Mr. Speaker,
year after year senior citizens throughout this country and those with
chronic illnesses cry out for prescription drug reform and lower
prices, but their cries and their tears go unheeded as the
pharmaceutical industry and their lobbyists defeat all efforts to lower
prices. Year after year those poor people come up here, bla, bla, bla,
bla, bla, and year after year every effort is defeated because the
pharmaceutical industry and their money machine prevents any real
reform.
Well, this year it is my hope that it will be different because
Congress is going to build on our successes from the last session of
Congress. Last year this Congress, in a bipartisan measure,
overwhelmingly passed legislation which promised the American people
that they would be able to buy prescription drugs at the same low
prices as do consumers in other countries through a reimportation
program. And that means that the United States, in the midst of a
global economy, that our prescription drug distributors, our
pharmacists, should be able to purchase FDA safety-inspected drugs from
any country where they can get a better price. If drugs are sold in
Canada for one-tenth the price, pharmacists in the United States should
be able to reimport those drugs under strict FDA safety regulations.
In the House last year, the Crowley reimportation amendment,
introduced by the gentleman from New York (Mr. Crowley), won by a 363
to 12 vote. Unfortunately, at the end of a long legislative process,
loopholes were put into the overall bill last year that made it
ineffective. While the law remains on the books, it has not been
implemented by either the Clinton or the Bush administrations. In an
increasingly globalized economy, where we import food and other
products from all over the world, it is incomprehensible that
pharmacists and prescription drug distributors are unable to import or
reimport FDA safety-approved drugs that were manufactured in FDA
approved facilities.
The pharmaceutical industry and their supporters in Congress are
sending out letters right now saying, oh, this is a dangerous idea, we
are going to be poisoning the American people. This is absolute
nonsense. Let me briefly read from a letter that was sent to Senator
Byron Dorgan on September 13, 2000 last year. And as many people know,
Dr. Kessler is the former FDA commissioner, I believe under both former
Presidents Bush and Clinton, and this is what he stated in his support
of reimportation last year, and I quote.
``I believe U.S. licensed pharmacists and wholesalers, who know how
drugs need to be stored and handled, and who would be importing them
under the strict oversight of the FDA, are well-positioned to safely
import quality products rather than having American consumers do this
on their own. Second, if the FDA is given the resources necessary to
ensure that imported FDA approved prescription drugs are the authentic
product, made in an FDA-approved manufacturing facility, I believe the
importation of these products can be done without causing a greater
health risk to American consumers than currently exists. Finally, as a
Nation, we have the best medical armamentarium in the world. Over the
years, FDA and the Congress have worked hard to assure the American
public has access to important medicine as soon as possible. But
developing lifesaving medications does not do any good unless Americans
can afford to buy the drugs their doctors prescribe. The price of
prescription drugs poses a major public health challenge. While we
should do nothing that compromises the safety and quality of
our medicine, it is important to take steps to make prescription drugs
more affordable.''
That is Dr. David Kessler, in a letter to Senator Byron Dorgan of
September 13, 2000.
Mr. Speaker, when the agricultural appropriations bill comes up,
perhaps on Thursday, perhaps next week, the gentleman from New York
(Mr. Crowley), the gentlewoman from Connecticut (Ms. DeLauro), and
others and I intend to introduce an amendment, the reimportation
amendment, which is the same amendment as the gentleman from New York
(Mr. Crowley) introduced last year that received, as I mentioned
before, 363 votes.
We know right now that the pharmaceutical industry's cash register is
clicking overtime. Their lobbyists are all over Washington trying to
scare Members of Congress so that they will not pass this legislation.
But I believe that when Members of Congress go into their hearts and
when they listen to the seniors and the other people back home who are
sick and tired of paying outrageously high prices for prescription
drugs, who are sick and tired of having to go to Canada and Mexico to
buy the drugs that they need, I believe that despite all of the scare
tactics of the pharmaceutical industry and their representatives in the
United States Congress, that Congress will have the guts to stand up to
them and vote for the American people and pass the Sanders-Crowley-
DeLauro reimportation amendment.
Mr. Speaker, when that amendment comes before the floor, it may be
the only opportunity this year or next year that Members of Congress
will have to vote to lower the outrageously high cost of prescription
drugs. I hope and am confident that Members of Congress will ignore the
scare tactics of the pharmaceutical industry and their representatives
and join the gentlewoman from Connecticut (Ms. DeLauro), the gentleman
from New York (Mr. Crowley), and myself, and many others from both
parties, in demanding that finally, after years and years of talk, we
lower the cost of prescription drugs in this country and we create a
situation in which American consumers do not have to continue paying
far more than people throughout the rest of the world for the same
exact prescription drugs.
[[Page H3600]]
Mr. Speaker, I want to thank my friend, the gentleman from New Jersey
(Mr. Pallone), for having yielded me his time, and I yield back the
balance of my time.
____________________